Making good time: The Tipline for 4 March 2019

Happy Monday! The Federal Trade Commission and Department of Justice have discussed the benefits of their new model timing agreements, the Actavis litigation has officially closed, and the House of Representatives’ antitrust subcommittee is set to take a closer look at the pharmaceutical industry in its first hearing under Democratic leadership.

Unlock unlimited access to all Global Competition Review content